kojic acid has been researched along with Skin Neoplasms in 9 studies
Skin Neoplasms: Tumors or cancer of the SKIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mannich bases of kojic acid derivatives may be promising therapeutic agents, since some have more potent effects on melanoma cells than previously FDA-approved drugs for the treatment of malignant melanoma." | 7.88 | Synthesis and Cytotoxic Evaluation of Kojic Acid Derivatives with Inhibitory Activity on Melanogenesis in Human Melanoma Cells. ( Aytemir, MD; Ercan, A; Karakaya, G; Oncul, S, 2018) |
| "Kojic acid is a natural product and normally used as a food additive and preservative, a skin-whitening agent in cosmetics, a plant growth regulator and a chemical intermediate." | 5.33 | Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells. ( Chen, ST; Cheng, SL; Huang Liu, R; Sheu, JN; Sinchaikul, S; Tsay, GJ, 2006) |
| "Mannich bases of kojic acid derivatives may be promising therapeutic agents, since some have more potent effects on melanoma cells than previously FDA-approved drugs for the treatment of malignant melanoma." | 3.88 | Synthesis and Cytotoxic Evaluation of Kojic Acid Derivatives with Inhibitory Activity on Melanogenesis in Human Melanoma Cells. ( Aytemir, MD; Ercan, A; Karakaya, G; Oncul, S, 2018) |
| "Kojic acid (KA) has been widely used as a quasi-drug ingredient." | 1.34 | Kojic acid -absence of tumor-initiating activity in rat liver, and of carcinogenic and photo-genotoxic potential in mouse skin. ( Hara, T; Higa, Y; Kariya, K; Kawabe, M; Kitamoto, S; Nabae, K; Takahashi, M; Tanaka, N; Toda, Y, 2007) |
| "Kojic acid is a natural product and normally used as a food additive and preservative, a skin-whitening agent in cosmetics, a plant growth regulator and a chemical intermediate." | 1.33 | Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells. ( Chen, ST; Cheng, SL; Huang Liu, R; Sheu, JN; Sinchaikul, S; Tsay, GJ, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Cardoso, R | 1 |
| Valente, R | 1 |
| Souza da Costa, CH | 1 |
| da S Gonçalves Vianez, JL | 1 |
| Santana da Costa, K | 1 |
| de Molfetta, FA | 1 |
| Nahum Alves, C | 1 |
| Karakaya, G | 1 |
| Ercan, A | 1 |
| Oncul, S | 1 |
| Aytemir, MD | 1 |
| Park, MH | 1 |
| Kim, SJ | 1 |
| Jeong, HO | 1 |
| Moon, KM | 1 |
| Son, S | 1 |
| Kim, DH | 1 |
| Kim, HR | 1 |
| Kim, MJ | 1 |
| Yun, HY | 1 |
| Chun, P | 2 |
| Je, NK | 1 |
| Yokozawa, T | 1 |
| Moon, HR | 2 |
| Chung, HY | 2 |
| Chen, MJ | 1 |
| Hung, CC | 1 |
| Chen, YR | 1 |
| Lai, ST | 1 |
| Chan, CF | 1 |
| Reddy, TL | 1 |
| Garikapati, KR | 1 |
| Reddy, SG | 1 |
| Reddy, BV | 1 |
| Yadav, JS | 1 |
| Bhadra, U | 1 |
| Bhadra, MP | 1 |
| Tsujii, H | 1 |
| Yamada, T | 1 |
| Kajimoto, T | 1 |
| Tanaka, R | 1 |
| Tokuda, H | 1 |
| Hasegawa, J | 1 |
| Hamashima, Y | 1 |
| Node, M | 1 |
| Bae, SJ | 1 |
| Ha, YM | 1 |
| Park, YJ | 1 |
| Park, JY | 1 |
| Song, YM | 1 |
| Ha, TK | 1 |
| Cheng, SL | 1 |
| Huang Liu, R | 1 |
| Sheu, JN | 1 |
| Chen, ST | 1 |
| Sinchaikul, S | 1 |
| Tsay, GJ | 1 |
| Higa, Y | 1 |
| Kawabe, M | 1 |
| Nabae, K | 1 |
| Toda, Y | 1 |
| Kitamoto, S | 1 |
| Hara, T | 1 |
| Tanaka, N | 1 |
| Kariya, K | 1 |
| Takahashi, M | 1 |
9 other studies available for kojic acid and Skin Neoplasms
| Article | Year |
|---|---|
Analysis of Kojic Acid Derivatives as Competitive Inhibitors of Tyrosinase: A Molecular Modeling Approach.
Topics: Catalytic Domain; Enzyme Inhibitors; Humans; Levodopa; Melanins; Melanocytes; Melanoma; Molecular Do | 2021 |
Synthesis and Cytotoxic Evaluation of Kojic Acid Derivatives with Inhibitory Activity on Melanogenesis in Human Melanoma Cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Mannich Bases; Me | 2018 |
Inhibition of melanogenesis by 2-[4-(5-chlorobenzo[d]thiazol-2-yl)phenoxy]-2-methylpropanoic acid (MHY908).
Topics: Agaricales; Animals; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Melanins; M | 2015 |
Novel synthetic kojic acid-methimazole derivatives inhibit mushroom tyrosinase and melanogenesis.
Topics: Agaricales; Animals; Biphenyl Compounds; Chick Embryo; Enzyme Inhibitors; Melanins; Melanoma, Experi | 2016 |
Simultaneous delivery of Paclitaxel and Bcl-2 siRNA via pH-Sensitive liposomal nanocarrier for the synergistic treatment of melanoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Drug Compounding; Drug Deli | 2016 |
Hybrids of 3alpha-methoxyserrat-14-en-21beta-ol (PJ-1) and 3beta-methoxyserrat-14-en-21beta-ol (PJ-2) and various anti-oxidants as cancer chemopreventive agents.
Topics: Animals; Antigens, Viral; Antineoplastic Agents; Antioxidants; Cell Line; Drug Screening Assays, Ant | 2010 |
Design, synthesis, and evaluation of (E)-N-substituted benzylidene-aniline derivatives as tyrosinase inhibitors.
Topics: Agaricales; alpha-MSH; Aniline Compounds; Animals; Antineoplastic Agents; Benzylidene Compounds; Cat | 2012 |
Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells.
Topics: Antioxidants; Cell Line, Tumor; Cell Survival; Computational Biology; Gene Amplification; Gene Expre | 2006 |
Kojic acid -absence of tumor-initiating activity in rat liver, and of carcinogenic and photo-genotoxic potential in mouse skin.
Topics: Administration, Oral; Animals; Antioxidants; Carcinogenicity Tests; Carcinogens; CHO Cells; Cricetin | 2007 |